Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2007 1
2009 1
2010 2
2011 5
2012 3
2013 3
2014 3
2015 3
2017 5
2018 3
2019 6
2020 8
2021 15
2022 8
2023 14
2024 8

Text availability

Article attribute

Article type

Publication date

Search Results

76 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for herrera k
Search for Herrala K instead (2 results)
Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas.
Gross AM, Dombi E, Wolters PL, Baldwin A, Dufek A, Herrera K, Martin S, Derdak J, Heisey KS, Whitcomb PM, Steinberg SM, Venzon DJ, Fisher MJ, Kim A, Bornhorst M, Weiss BD, Blakeley JO, Smith MA, Widemann BC. Gross AM, et al. Among authors: herrera k. Neuro Oncol. 2023 Oct 3;25(10):1883-1894. doi: 10.1093/neuonc/noad086. Neuro Oncol. 2023. PMID: 37115514 Free PMC article. Clinical Trial.
Global healthcare fairness: We should be sharing more, not less, data.
Seastedt KP, Schwab P, O'Brien Z, Wakida E, Herrera K, Marcelo PGF, Agha-Mir-Salim L, Frigola XB, Ndulue EB, Marcelo A, Celi LA. Seastedt KP, et al. Among authors: herrera k. PLOS Digit Health. 2022 Oct 6;1(10):e0000102. doi: 10.1371/journal.pdig.0000102. eCollection 2022 Oct. PLOS Digit Health. 2022. PMID: 36812599 Free PMC article. Review.
miRNAs and Novel Food Compounds Related to the Browning Process.
Lorente-Cebrián S, Herrera K, I Milagro F, Sánchez J, de la Garza AL, Castro H. Lorente-Cebrián S, et al. Among authors: herrera k. Int J Mol Sci. 2019 Nov 28;20(23):5998. doi: 10.3390/ijms20235998. Int J Mol Sci. 2019. PMID: 31795191 Free PMC article. Review.
Phase I trial of Ganitumab plus Dasatinib to Cotarget the Insulin-Like Growth Factor 1 Receptor and Src Family Kinase YES in Rhabdomyosarcoma.
Akshintala S, Sundby RT, Bernstein D, Glod JW, Kaplan RN, Yohe ME, Gross AM, Derdak J, Lei H, Pan A, Dombi E, Palacio-Yance I, Herrera KR, Miettinen MM, Chen HX, Steinberg SM, Helman LJ, Mascarenhas L, Widemann BC, Navid F, Shern JF, Heske CM. Akshintala S, et al. Among authors: herrera kr. Clin Cancer Res. 2023 Sep 1;29(17):3329-3339. doi: 10.1158/1078-0432.CCR-23-0709. Clin Cancer Res. 2023. PMID: 37398992 Free PMC article. Clinical Trial.
76 results